The Latin America NGS market was valued at $268.04 million in 2024 and is anticipated to reach $597.20 million by 2034, witnessing a CAGR of 8.34% during the forecast period 2024-2034.
The ultrasound market in Brazil was valued at $118.5 million in 2022 and is anticipated to grow to $209.2 million by the end of 2030, at a projected CAGR of 7.49% during the forecast period 2023-2030.
The U.S. breast cancer screening and diagnostic market was valued at $1,556.6 million in 2024 and is anticipated to reach $2,342.2 million by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-2030.
The global urinary bag market was valued at $649.0 million in 2023 and is anticipated to grow to $976.8 million by the end of 2033, at a projected CAGR of 4.17% during the forecast period 2024-2033.
The Asia-Pacific cell and gene therapy manufacturing QC market was valued at $246.4 million in 2023 and is anticipated to reach $1,317.3 million by 2033, witnessing a CAGR of 18.36% during the forecast period 2024-2033.
Need reports on an on-going basis? Do consider our annual subscription
The Australia NIPT market was valued at $40.0 million in 2023 and is expected to reach $110.7 million by 2033, registering a CAGR of 10.71% during the forecast period 2024-2033.
The Europe robotic surgery consumables market was valued at $848.5 million in 2023 and is expected to reach $2,856.4 million by 2033, growing at a CAGR of 12.91% during the forecast period 2023-2033.
The Asia-Pacific robotic surgery consumables market was valued at $654.3 million in 2023 and is expected to reach $2,293.1 million by 2033, growing at a CAGR of 13.36% during the forecast period 2023-2033.
The Europe targeted sequencing market was valued at $803.8 million in 2023 and is expected to reach $2,373.3 million by 2033, growing at a CAGR of 11.53% between 2024 and 2033.
The Asia-Pacific Targeted Sequencing Market was valued at $574.2 million in 2023 and is expected to reach $2,175.5 million by 2033, growing at a CAGR of 14.35% between 2024 and 2033.
The Europe precision medicine software market was valued at $416.1 million in 2023 and is expected to reach $1,224.7 million by 2033, growing at a CAGR of 11.47% between 2024 and 2033.
The Europe Microarray Analysis Market was valued at $1,690.2 million in 2023 and is expected to reach $3,236.0 million by 2033, growing at a CAGR of 6.71% during the forecast period 2023-2033.
The global protein sequencing market is projected to reach $2,697.0 million by 2033 from $1,749.0 million in 2023, growing at a CAGR of 4.36% during the forecast period 2024-2033.
The Europe aseptic connectors market was valued at $198.8 million in 2023 and is expected to reach $472.9 million by 2033, growing at a CAGR of 9.05% between 2023 and 2033.
The Asia-Pacific metagenomics market was valued at $376.1 million in 2023 and is expected to reach $2,238.0 million by 2033, growing at a CAGR of 19.65% between 2024 and 2033.
The global digital PCR (d-PCR) market is projected to reach $3,351.0 million by 2034 from $678.1 million in 2023, growing at a CAGR of 15.75% during the forecast period 2024-2034.
The Europe companion diagnostics market was valued at $1,116.5 million in 2023 and is expected to reach $3,562.1 million by 2033, growing at a CAGR of 12.30% between 2023 and 2033.
The Europe HPLC market was estimated at $1,269.2 million in 2023 and is expected to reach $2,014.3 million by 2033, growing at a CAGR of 4.73% during the forecast period 2023-2033.
The Asia-Pacific digital diagnostics market is projected to reach $2,029.9 million by 2033 from $314.7 million in 2023, growing at a CAGR of 20.49% during the forecast period 2023-2033.
The Europe dental infections control market is projected to reach $758.3 million by 2033 from $390.3 million in 2023, growing at a CAGR of 6.87% during the forecast period 2023-2033.
The Asia-Pacific DNA methylation detection technology market was valued at $443.6 million in 2023 and is expected to reach $2,280.6 million by 2033, growing at a CAGR of 17.79% between 2023 and 2033.
The global whole genome and exome sequencing market is projected to reach $7,467.6 million by 2033 from $1,873.8 million in 2023, growing at a CAGR of 15.13% during the forecast period 2024-2033.
The Asia-Pacific Automated Sample Preparation Market was valued at $317.5 million in 2023 and is expected to reach $969.6 million by 2033, growing at a CAGR of 11.81% between 2023 and 2033.
The Asia-Pacific continuous bioprocessing market was valued at $51.0 million in 2023 and is expected to reach $388.5 million by 2033, growing at a CAGR of 22.50% between 2023 and 2033.
The Europe digital surgery technologies market is projected to reach $3,769.2 million by 2033 from $215.7 million in 2023, growing at a CAGR of 33.12% during the forecast period 2023-2033.
The Europe automated sample preparation market was valued at $381.3 million in 2023 and is expected to reach $925.1 million by 2033, growing at a CAGR of 9.27% between 2023 and 2033.
In an optimistic scenario, the market, valued at $8.7 million in 2024, is anticipated to grow at a CAGR of 15.43%, reaching $36.7 million by 2034.
The Asia-Pacific protein expression market was valued at $530.6 million in 2023 and is expected to reach $1,809.8 million by 2033, growing at a CAGR of 13.05% between 2023 and 2033.
The global mass spectrometry and chromatography in diagnostics market was valued at $743.1 million in 2023 and is expected to reach $1,863.8 million by 2033, growing at a CAGR of 9.92% during the forecast period 2024-2033.
The global ENT devices market was valued at $17.02 billion in 2023 and is expected to reach $30.82 billion by 2033, growing at a CAGR of 6.03% during the forecast period 2024-2033.
The global hematologic malignancies testing market was valued at $3,546.3Â million in 2023 and is expected to reach $13,509.5Â million by 2033, growing at a CAGR of 14.09% during the forecast period 2024-2033.
The global liquid biopsy market was valued at $4,072.6 million in 2023 and is expected to reach $20,224.7 million by 2033, growing at a CAGR of 16.83% during the forecast period 2024-2033.
The global hereditary genetic testing market is projected to reach $81.95 billion by 2033 from $24.78 billion in 2023, growing at a CAGR of 12.73% during the forecast period 2024-2033.
The Asia-Pacific synthetic hormones market size was estimated at $2.41 billion in 2023 and is expected to reach $4.89 billion by 2033, growing at a CAGR of 7.34% during the forecast period 2023-2033.
The Asia-Pacific dental infections control market is projected to reach $627.7 million by 2033 from $300.5 million in 2023, growing at a CAGR of 7.64% during the forecast period 2023-2033.
The global metagenomics market was valued at $1,808.0 million in 2023 and is expected to reach $9,286.1 million by 2033, growing at a CAGR of 17.90% between 2024 and 2033.
The global surgical robotics simulation market was valued at $427.9 million in 2023 and is expected to reach $2,132.3 million by 2033, growing at a CAGR of 17.31% between the forecast period of 2024-2033.
The Europe highly potent API market is projected to reach $16.33 billion by 2033 from $5.98 billion in 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033.
The global genome sequencing market was valued at $7.56 billion in 2023 and is expected to reach $30.23 billion by 2033, growing at a CAGR of 15.18% between 2024 and 2033.
The Europe synthetic hormones market size was estimated at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033.
The Europe digital therapeutics market is projected to reach $13.91 billion by 2033 from $1.68 billion in 2023, growing at a CAGR of 23.54% during the forecast period 2023-2033.
Expected to grow from a base of $1.02 billion in 2024, the market is projected to experience a compound annual growth rate (CAGR) of 8.43%, reaching approximately $2.29 billion by 2034.
The global advanced wound dressing market is projected to reach $8,383.1 million by 2030 from $6,418.5 million in 2023, growing at a CAGR of 3.89% during the forecast period 2023-2030.
The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023.
The global non-silicone foam dressings market is projected to reach $699.7 million by 2030 from $529.4 million in 2023, growing at a CAGR of 4.07% during the forecast period 2023-2030.
The global non-silver antimicrobial dressings market is projected to reach $565.8 million by 2030 from $437.2 million in 2023, growing at a CAGR of 3.75% during the forecast period 2023-2030.
The global organ-on-chip market is projected to reach $3,596.3 million by 2033 from $109.9 million in 2023, growing at a CAGR of 42.09% during the forecast period 2024-2033.
The Europe interventional imaging market is projected to reach $4.23 billion by 2033 from $2.23 billion in 2023, growing at a CAGR of 6.62% during the forecast period 2023-2033.
The global wound therapy devices market is projected to reach $6,473.5 million by 2030 from $4,781.7 million in 2023, growing at a CAGR of 4.42% during the forecast period 2023-2030.
The global wound skin substitutes market is projected to reach $2,062.6 million by 2030 from $1,255.5 million in 2023, growing at a CAGR of 7.35% during the forecast period 2023-2030.
The global PMS and menstrual health supplements market was valued at $21.68 billion in 2023 and is expected to reach $37.23 billion by 2033, growing at a CAGR of 5.45% between 2023 and 2033.
The global medical tape and bandages market is projected to reach $4,490.8 million by 2030 from $3,750.5 million in 2023, growing at a CAGR of 2.61% during the forecast period 2023-2030.
The global silicone scar dressing market is projected to reach $495.6 million by 2030 from $318.9 million in 2023, growing at a CAGR of 6.50% during the forecast period 2023-2030.
The Europe MRD testing market is projected to reach $1,744.0Â million by 2033 from $424.0Â million in 2023, growing at a CAGR of 15.19% during the forecast period 2023-2033.
The global dental implants and prosthetics market has been valued at $11.44 billion in 2024 and is expected to grow at a CAGR of 7.09% to reach $22.70 billion by 2034
The global surgical/sharp debridement market was valued at $209.7 million in 2023 and is anticipated to reach $295.9 million by 2030, witnessing a CAGR of 5.05% during the forecast period 2023-2030.
The global wound electrical stimulation devices market was valued at $207.5 million in 2023 and is anticipated to reach $328.4 million by 2030, witnessing a CAGR of 6.78% during the forecast period 2023-2030.
Considering the optimistic scenario, the global medical robots market has been valued at $16.39 billion in 2024 and is expected to grow at a CAGR of 18.31%.
The global wound biologics market was valued at $1,974.7 million in 2023 and is anticipated to reach $3,321.5 million by 2030, witnessing a CAGR of 7.71% during the forecast period 2023-2030.
The global hyperbaric oxygen therapy market was valued at $480.0 million in 2023 and is anticipated to reach $734.1 million by 2030, witnessing a CAGR of 6.26% during the forecast period 2023-2030.
The global silver antimicrobial dressings market was valued at $1,014.0 million in 2023 and is anticipated to reach $1,256.3 million by 2030, witnessing a CAGR of 3.11% during the forecast period 2023-2030.
The global enzymatic debridement market was valued at $553.2 million in 2023 and is anticipated to reach $826.1 million by 2030, witnessing a CAGR of 5.90% during the forecast period 2023-2030.
The global hydrocolloid dressings market was valued at $816.6 million in 2023 and is anticipated to reach $1,029.9 million by 2030, witnessing a CAGR of 3.37% during the forecast period 2023-2030.
The global silicone foam dressings market was valued at $1,263.4 million in 2023 and is anticipated to reach $1,731.2 million by 2030, witnessing a CAGR of 4.60% during the forecast period 2023-2030.
The global offloading devices market was valued at $1,207.5 million in 2023 and is anticipated to reach $1,546.6 million by 2030, witnessing a CAGR of 3.60% during the forecast period 2023-2030.
The global compression bandages market was valued at $769.4 million in 2023 and is anticipated to reach $1,019.3 million by 2030, witnessing a CAGR of 4.10% during the forecast period 2023-2030.
The Europe DNA/RNA sample extraction and isolation market was valued at $629.0 million in 2023 and is expected to reach $1,236.2 million by 2033, growing at a CAGR of 6.99% between 2023 and 2033.
The global mechanical debridement market was valued at $363.6 million in 2023 and is anticipated to reach $536.0 million by 2030, witnessing a CAGR of 5.70% during the forecast period 2023-2030.
The global wound growth factors market was valued at $421.7 million in 2023 and is anticipated to reach $750.7 million by 2030, witnessing a CAGR of 8.59% during the forecast period 2023-2030.
The global hydrogel dressings market was valued at $191.7 million in 2023 and is anticipated to reach $260.0 million by 2030, witnessing a CAGR of 4.45% during the forecast period 2023-2030.
The global negative pressure wound therapy (NPWT) market was valued at $2,117.3 million in 2023 and is anticipated to reach $2,845.1 million by 2030, witnessing a CAGR of 4.31% during the forecast period 2023-2030.
The global ultrasonic debridement market was valued at $145.6 million in 2023 and is anticipated to reach $240.6 million by 2030, witnessing a CAGR of 7.43% during the forecast period 2023-2030.
The global contact layer dressings market was valued at $557.2 million in 2023 and is anticipated to reach $712.6 million by 2030, witnessing a CAGR of 3.58% during the forecast period 2023-2030.
The global alginate dressings market was valued at $393.1 million in 2023 and is anticipated to reach $519.8 million by 2030, witnessing a CAGR of 4.07% during the forecast period 2023-2030.
The global collagen dressings market was valued at $477.2 million in 2023 and is anticipated to reach $613.1 million by 2030, witnessing a CAGR of 3.65% during the forecast period 2023-2030.
The global film dressings market was valued at $525.9 million in 2023 and is anticipated to reach $695.9 million by 2030, witnessing a CAGR of 4.08% during the forecast period 2023-2030.
The global superabsorbent dressings market was valued at $212.8 million in 2023 and is anticipated to reach $298.8 million by 2030, witnessing a CAGR of 4.97% during the forecast period 2023-2030.
The Europe scar management market was valued at $238.5 million in 2023 and is anticipated to reach $351.0 million by 2030, witnessing a CAGR of 5.67% during the forecast period 2023-2030.
The Asia-Pacific wearable patches market was valued at $2,268.6 million in 2023 and is expected to reach $5,300.6 million by 2031, growing at a CAGR of 11.19% between 2023 and 2031.
The global robotic surgery consumables market was valued at $4.87 billion in 2023 and is expected to reach $15.61 billion by 2033, growing at a CAGR of 12.34% during the forecast period 2023-2033.
The global targeted sequencing market was valued at $3,479.8 million in 2023 and is expected to reach $10,987.4 million by 2033, growing at a CAGR of 12.28% between 2024 and 2033.
The global computed tomography market is projected to reach $10.21 billion by 2033 from $6.17 billion in 2023, growing at a CAGR of 5.22% during the forecast period 2024-2033.
The global precision medicine software market was valued at $1,824.9 million in 2023 and is expected to reach $5,696.3 million by 2033, growing at a CAGR of 12.13% between 2024 and 2033.
The global NIPT market was valued at $3,350.4 million in 2023 and is expected to reach $12,870.9 million by 2033, registering a CAGR of 14.41% during the forecast period 2023-2033.
The global wound debridement market was valued at $1,272.0 million in 2023 and is expected to reach $1,898.6 million by 2030, growing at a CAGR of 5.89% during the forecast period 2023-2030.
The global microarray analysis market was valued at $5,357.9 million in 2023 and is expected to reach $10,112.4 million by 2033, growing at a CAGR of 6.56% during the forecast period 2023-2033.
The global companion diagnostics market was valued at $3,762.0Â million in 2023Â and is expected to reach $12,498.7 million by 2033, growing at a CAGR of 12.76% between 2023 and 2033.
The global HPLC market was estimated at $5.23 billion in 2023 and is expected to reach $8.22 billion by 2033, growing at a CAGR of 4.61% during the forecast period 2023-2033.
The global aseptic connectors market was valued at $746.7 million in 2023 and is expected to reach $1,907.0 million by 2033, growing at a CAGR of 9.83% between 2023 and 2033.
The Europe wound cleanser market was valued at $460.7 million in 2023 and is expected to reach $564.8 million by 2030, growing at a CAGR of 2.95% between 2023 and 2030.
The Europe rare disease genetic testing market was valued at $1.16 billion in 2023 and is anticipated to reach $4.17 billion by 2033, witnessing a CAGR of 13.60% during the forecast period 2023-2033.
The global colorectal cancer screening and diagnostics market was valued at $38,540.7 million in 2023 and is expected to reach $48,710.9 million by 2033, growing at a CAGR of 2.37% during the forecast period 2023-2033.
The global nucleic acid sample preparation market is projected to reach $5,615.9Â million by 2033 from $2,922.8Â million in 2023, growing at a CAGR of 6.75% during the forecast period 2023-2033.
The MRD testing market was valued at $1.47 billion in 2022 and is expected to reach $6.67 billion by 2033, growing at a CAGR of 14.81% between 2023 and 2033.
The global digital diagnostics market is projected to reach $8,319.2 million by 2033 from $1,431.7 million in 2023, growing at a CAGR of 19.24% during the forecast period 2023-2033.
The Asia-Pacific next-generation IVD market was valued at $21.43 billion in 2023 and is expected to reach $42.35 billion by 2033, growing at a CAGR of 7.05% between 2023 and 2033.
The Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market is projected to reach $1,779.4 Million by 2032 from $554.3 Million in 2023, growing at a CAGR of 13.84% during the forecast period 2023-2032.
In 2023, the Asia-Pacific organ transplant diagnostics market was valued at $1.25 billion and is expected to reach $3.45 billion by 2033, with a CAGR of 10.73% during the forecast period 2023-2033.
The Europe contrast media agent and injector system market was valued at $2,141.5 million in 2022 and is expected to reach $2,740.6 million by 2026, growing at a CAGR of 6.36% during the forecast period 2022-2026.
The global automated sample preparation market was valued at $1,431.9Â million in 2023Â and is expected to reach $3,730.5 million by 2033, growing at a CAGR of 10.05% between 2023 and 2033.
The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033.
The Europe cell and gene therapy manufacturing Quality Control (QC) market is expected to reach $2,545.6 million by 2033 from $534.3 million in 2023 at a CAGR of 16.90% during the forecast period 2023-2033.
The global digital surgery technologies market is projected to reach $12,997.3 million by 2033 from $783.2 million in 2023, growing at a CAGR of 32.43% during the forecast period 2023-2033.
The global continuous bioprocessing market was valued at $250.1 million in 2023 and is expected to reach $1,639.1 million by 2033, growing at a CAGR of 20.68% between 2023 and 2033.
In 2023, the Europe functional genomics market was valued at $3.01 billion, and it is expected to reach $10.69 billion by 2033.
The Asia-Pacific single-cell multi-omics market is projected to reach $1.85 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 20.00% during the forecast period 2023-2033.
The Europe nucleic acid therapeutics CDMO market was valued at $1.27 billion in 2023 and is expected to reach $3.88 billion by 2033, growing at a CAGR of 11.80% during the forecast period 2023-2033.
The Asia-Pacific gene editing technologies market was valued at $0.49 billion in 2023 and is anticipated to reach $5.05 billion by 2032, witnessing a CAGR of 29.64% during the forecast period 2023-2032.
The global DNA methylation detection technology market was valued at $2.80 billion in 2023 and is expected to reach $12.32 billion by 2033, growing at a CAGR of 15.96% between 2023 and 2033.
The Asia-Pacific cell-based assay market was valued at $4.05 billion in 2023 and is anticipated to reach $9.19 billion by 2032, witnessing a CAGR of 9.53% during the forecast period 2023-2032.
The Europe multicancer screening market is projected to reach $2.09 billion by 2032 from $0.55 billion in 2023, growing at a CAGR of 15.93% during the forecast period 2023-2032.
The global protein expression market was valued at $2,393.0 million in 2023 and is expected to reach $6,963.6 million by 2033, growing at a CAGR of 11.27% between 2023 and 2033.
The market size was estimated at $19.40 billion in 2023 and is expected to reach $38.08 billion by 2033, growing at a CAGR of 6.98% during the forecast period 2023-2033.
The global dental infections control market is projected to reach $2,445.4 million by 2033 from $1,292.4 million in 2023, growing at a CAGR of 6.59% during the forecast period 2023-2033.
The global clinical biomarkers market was valued at $24.80 billion in 2023 and is expected to reach $53.20 billion by 2033, growing at a CAGR of 7.93% between 2023 and 2033.
The global highly potent API market is projected to reach $84.20 billion by 2033 from $27.44 billion in 2023, growing at a CAGR of 11.86% during the forecast period 2023-2033.
The Europe gene fusion testing market was valued at $71.4 million in 2023 and is anticipated to reach $248.2 million by 2033, witnessing a CAGR of 13.27% during the forecast period 2023-2033.
The market size is anticipated to be $0.06 billion in 2026 and is expected to reach $7.72 billion by 2040, growing at a CAGR of 41.55% during the forecast period 2026-2040.
The Korea centrifugation market was valued at $46.1 million in 2023 and is expected to reach $80.6 million by 2033, growing at a CAGR of 5.75% between 2023 and 2033.
The Asia-Pacific contrast media agent and injector system market was valued at $1.98 billion in 2022 and is expected to reach $2.62 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2022-2026.
The Asia-Pacific NGS data storage market is projected to reach $1,284.3 million by 2033 from $207.5 million in 2023, growing at a CAGR of 19.99% during the forecast period 2023-2033.
The global veterinary vaccine market is projected to reach $19.86 billion by 2033 from $9.82 billion in 2023, growing at a CAGR of 7.30% during the forecast period 2023-2033.
The Europe artificial intelligence/machine learning medical device market was valued at $1.01 billion in 2022 and is expected to reach $7.93 billion by 2032, witnessing a CAGR of 22.95% during the forecast period 2022-2032.
The Europe minimally invasive spine technologies market was valued at $691.1 million in 2022 and is anticipated to reach $2,116.5 million by 2032, witnessing a CAGR of 11.84% during the forecast period 2022-2032.
The Europe autonomous surgical robotics market was valued at $432.7 million in 2023 and is expected to reach $2,157.0 million by the end of 2033.
As of 2023, the Europe genomic cancer panel and profiling market was valued at $2.64 billion and is expected to attain a value of $6.50 billion in 2033.
The Asia-Pacific interventional imaging market was valued at $1.11 billion in 2023 and is expected to reach $2.44 billion by the end of 2033, growing at a CAGR of 8.18% during the forecast period 2023-2033.
The sleep apnea oral appliances market report presents an extensive overview of the industry, encompassing both qualitative and quantitative data.
This report aims to provide a comprehensive analysis of the single use assemblies market, focusing on current unmet needs, trends, challenges and opportunities shaping the industry landscape.
The global healthcare cloud computing market report provides a comprehensive analysis of the current trends, market size, growth drivers, and challenges in the healthcare cloud computing industry.
The global elderly care services market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
Asia-Pacific Advanced Dental Digital and Robotics Solutions Market: Analysis and Forecast, 2023-2032
In 2023, the Asia-Pacific advanced dental digital and robotics solutions market was valued at $0.8 billion and is expected to reach $2.1 billion by 2032.
The global bioprocess bags and containers market report offers a detailed assessment of market segments, including product type and end user, elucidating their respective market shares and growth prospects.
The bioprocessing probes and sensors market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The report delves into various factors influencing the industry, including recent trends, recent advancements, and regulatory aspects.
This comprehensive report provides a detailed analysis of market trends, key players, and growth opportunities within the veterinary equipment and supplies sector.
The Asia-Pacific rare disease genetic testing market was valued at $0.51 billion in 2022 and is expected to reach $2.40 billion by 2033, witnessing a CAGR of 15.25% during the forecast period 2023-2033.
The Europe acute care syndromic testing market was valued at $0.90 billion in 2022 and is expected to reach $2.32 billion by 2033, growing at a CAGR of 8.95% between 2023 and 2033.
The Europe cardiac AI monitoring and diagnostics market was valued at $275.6 million in 2022 and is anticipated to reach $3,199.9 million by 2032, witnessing a CAGR of 28.09% during the forecast period 2023-2032.
The Europe EV-based liquid biopsy market was valued at $18.88 million in 2022 and is anticipated to reach $115.34 million by 2032.
The global pen needle market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The report offer a comprehensive overview of the microcarriers market, highlighting key trends, growth drivers, challenges, and opportunities shaping this dynamic industry.
The report contains crucial statistics concerning the status of prominent players in the cystatin C assay market, highlighting key trends and potential opportunities within the market.
The Asia-Pacific wound cleanser market was valued at $547.4 million in 2022 and is expected to reach $754.6 million by 2030, growing at a CAGR of 4.10% during the forecast period 2023-2030.
The Asia-Pacific laboratory automation market was valued at $1.17 billion in 2022 and is expected to reach $3.69 billion by the end of 2033, registering a CAGR of 11.03% during the forecast period 2023-2033.
The remote patient monitoring (RPM) market report provides a comprehensive analysis of the global market for remote patient monitoring technologies and services.
The immunoassay plays a pivotal role in diagnostics and therapeutic applications, encompassing a wide range of techniques such as ELISA, western blotting, radioimmunoassay, and rapid tests.
The Europe wearable patches market was valued at $3.03 billion in 2022 and is expected to reach $7.85 billion by 2031, growing at a CAGR of 10.29% between 2023 and 2031.
The global digital therapeutics market is projected to reach $46.80 billion by 2033 from $4.90 billion in 2022, growing at a CAGR of 22.93% during the forecast period 2023-2033.
The hemostats market report provides a comprehensive analysis of presents an extensive overview of the industry, encompassing both qualitative and quantitative data.
The global fetal and neonatal care equipment market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
Global Restorative Dentistry Market rising prevalence of oral health diseases, a heightened emphasis on aesthetics, and the growing trend of dental tourism in emerging markets.
The study evaluates the competitive landscape, profiling leading players, and assessing their strategies to gain a competitive edge.
The MEA cosmeceuticals market is experiencing robust growth due to several key factors. Firstly, there is a rising awareness and demand for skincare and beauty products among the population in the region.
The global antibody therapeutic market occupies a pivotal role within the biopharmaceutical and life sciences sectors, dedicated to the manufacturing, advancement, and commercialization of antibodies with diverse applications in medical and research domains.
This report aims to provide a comprehensive analysis of the ALL market, focusing on current unmet needs, trends, challenges and opportunities shaping the industry landscape.
The global tympanometer market research report offers a detailed insight into the market, providing an in-depth analysis of the market's current prospects.
The global CRRT market is witnessing significant growth, driven by the increasing prevalence of acute kidney injuries (AKI) and the rising demand for advanced renal care solutions.
This comprehensive report provides a detailed analysis of market trends, key players, and growth opportunities within the bariatric surgery sector.
Global bioprocessing validation market report serves as a valuable resource for industry participants, investors, and decision-makers seeking to navigate the dynamic landscape.
ELISpot and FluoroSpot Assay Market play a crucial role in immunological research and diagnostics, and this report projects the market landscape on a global scale.
The respiratory diagnostics market is a rapidly growing focused on the diagnosis and monitoring of various respiratory conditions.
The market is expected to grow at a CAGR of 15.43% during the forecast period 2023-2032 and attain a value of $80.05 billion by 2032.
The global market for urological devices plays a crucial role in diagnosing and treating a diverse range of urological conditions, including urolithiasis, urethral malignancies, bladder disorders, and kidney diseases.
The report constitutes an extensive study of GCC Veterinary Laboratories industry.
This comprehensive report offers an in-depth analysis of the Global Surgical Sutures Market, covering key trends, market dynamics, competitive landscape, and future projections.
The global pharmaceutical excipients market is witnessing robust growth due to the increasing demand for pharmaceutical formulations and rising focus on drug delivery systems.
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
The market's expansion is driven by factors such as increasing incidence of cancer, continuous technological advancements such as the development of MRI linear accelerators, proton therapy, and the introduction of treatment planning software that integrates with imaging data.
The transdermal patches market encompasses a dynamic sector within the pharmaceutical industry that focuses on the development, manufacturing, and distribution of patches designed for drug delivery through the skin.
Digital health refers to the integration of digital technologies, such as software, mobile devices, telemedicine, wearable sensors, artificial intelligence (AI), and other technological tools, into healthcare and medicine.
The global genomic cancer panel and profiling market is expected to reach $26.59 billion by 2033 from $9.90 billion in 2022.
The report highlights the transformative impact of biologic therapies on individuals suffering from chronic inflammatory diseases, showcasing how these treatments have not only reduced dependency on health and welfare systems but also improved patients' physical function, enabling them to live more independently.
The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032.
The global autonomous surgical robotics market was valued at $1.81 billion in 2022 and is anticipated to reach $11.07 billion by 2033.
As of 2022, the Asia-Pacific multicancer screening market was valued at $0.27 billion and is expected to attain a value of $1.40 billion by 2032.
The Asia-Pacific medical X-Ray detectors market was valued at $508.2 million in 2022 and is anticipated to grow to $913.7 million by the end of 2032.
The global interventional imaging market is projected to reach $16.93 billion by 2033 from $8.66 billion in 2022, growing at a CAGR of 6.71% during the forecast period 2023-2033.
The Europe nucleic acid sample preparation market is projected to reach $3,356.7 million by 2032 from $1,307.4 million in 2022, growing at a CAGR of 9.89% during the forecast period 2022-2032.
The Asia-Pacific surgical robotics market was valued at $1,637.6 million in 2022 and is expected to reach $8,068.7 million by the end of 2032, registering a CAGR of 17.29% during the forecast period 2022-2032.
The global advanced dental digital and robotics solutions market was valued at $3.82 billion in 2022 and is anticipated to reach $8.99 million by 2032, witnessing a CAGR of 9.15% during the forecast period 2023-2032.
The Asia-Pacific cell and gene therapy biomanufacturing market was valued at $1.96 billion in 2022 and is expected to reach $8.60 billion by the end of 2031, growing at a CAGR of 17.88% during the forecast period 2022-2031.
Asia-Pacific nucleic acid therapeutics CDMO market was valued at $0.97 billion in 2022 and is expected to reach $4.04 billion by 2033.
In 2022, the India emerging infectious disease diagnostics market was valued at $339.1 million and is expected to grow at a CAGR of 10.29% during the forecast period 2023-2033 to register a value of $982.7 million in 2033.
The global medical and surgical drainage system market was valued at $2,468.7 million in 2022 and is expected to reach $3,073.4 million by 2027, growing at a CAGR of 4.86% between 2023 and 2027.
The global biopsy devices market is projected to reach $11,869.4 million by 2027 from $5,852.8 million in 2022, growing at a CAGR of 15.15% during the forecast period 2023-2027.
The market is expected to grow at a CAGR of 7.07% during the forecast period 2023-2033 and attain a value of $4.79 billion by 2033.
The global wearable patches market was valued at $10,462.4 million in 2022 and is expected to reach $26,892.7 million by 2031, growing at a CAGR of 10.19% between 2023 and 2031.
The global scar management market was valued at $1,040.1 million in 2022 and is anticipated to reach $1,594.4 million by 2030, witnessing a CAGR of 5.53% during the forecast period 2023-2030.
The global wound cleanser market was valued at $1,873.4 million in 2022 and is expected to reach $2,434.3 million by 2030, growing at a CAGR of 3.34% between 2023 and 2030.
The global laboratory automation market was valued at $9.17 billion in 2022 and is anticipated to reach $24.84 billion by 2033, witnessing a CAGR of 9.57% during the forecast period 2023-2033.
The global gene fusion testing market was valued at $255.3 million in 2022 and is anticipated to reach $897.6 million by 2033, witnessing a CAGR of 12.25% during the forecast period 2023-2033.
The global cell and gene therapy biomanufacturing CDMO market - focused on AAV was valued at $231.3 million in 2022 and is anticipated to reach $2,566.6 million by 2033, witnessing a CAGR of 24.61% during the forecast period 2023-2033.
The global rare disease genetic testing market was valued at $4.11 billion in 2022 and is anticipated to reach $16.69 billion by 2033, witnessing a CAGR of 13.69% during the forecast period 2023-2033.
The global cardiac AI monitoring and diagnostics market was valued at $1,010.5 million in 2022 and is anticipated to reach $10,666.5 million by 2032, witnessing a CAGR of 26.88% during the forecast period 2023-2032.
The next-generation IVD market was valued at $86.21 billion in 2022 and is expected to reach $152.62 billion by 2033, growing at a CAGR of 5.41% between 2023 and 2033.
The global emerging infectious disease diagnostics market was valued at $19.56 billion in 2022 and is expected to reach $37.21 billion by 2033, growing at a CAGR of 6.19% between 2023 and 2033.
The global EV-based liquid biopsy market was valued at $78.22 million in 2022 and is anticipated to reach $455.53 million by 2032, witnessing a CAGR of 19.73% during the forecast period 2023-2032.
The global acute care syndromic testing market was valued at $3.14 billion in 2022 and is expected to reach $8.44 billion by 2033, growing at a CAGR of 9.43% between 2023 and 2033.
The global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032.
The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is anticipated to reach $10.65 billion by 2033, witnessing a CAGR of 16.85% during the forecast period 2023-2033.
The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.
The global NGS market was valued at $6.76 billion in 2022 and is expected to reach $28.47 billion by 2033, growing at a CAGR of 13.97% during the forecast period 2023-2033.
The global contrast media agent and injector system market was valued at $7,634.6 million in 2022 and is expected to reach $9,712.3 million by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026.
The global colorectal cancer screening and diagnostic market was valued at $15.28 billion in 2022 and is expected to reach $28.52 billion by 2033, growing at a CAGR of 5.93% during the forecast period 2023-2033.
The global constrained peptide drugs market is expected to reach $17.38 billion in 2040 from $0.06 billion in 2024, growing at a CAGR of 38.94% during the forecast period 2025-2040.
The global single-cell multi-omics market is projected to reach $7.72 billion by 2033 from $1.43 billion in 2022, growing at a CAGR of 17.27% during the forecast period 2023-2033.
The global NGS data storage market is projected to reach $6.96 billion by 2033 from $1.13 billion in 2022, growing at a CAGR of 18.02% during the forecast period 2023-2033.
In 2022, the global functional genomics market was valued at $10.57 billion, and it is expected to reach $46.24 billion by 2033, growing at a CAGR of 14.04% during the forecast period 2023-2033.
The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032.
A monthly review of how COVID-19 is impacting the diagnostics, therapeutics, and vaccines market. Overall, more than 225 treatment options were reported in April 2023.
The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach $16.37 billion by 2032, witnessing a CAGR of 27.50% during the forecast period 2023-2032.
In 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033, with a CAGR of 10.45% during the forecast period 2023-2033.
The global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032.
The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032.
The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033.
The global minimally invasive spine technologies market was valued at $3,180.9 million in 2022 and is anticipated to reach $9,406.5 million by 2032, witnessing a CAGR of 11.45% during the forecast period 2022-2032.
The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by 2027, witnessing a CAGR of 17.56% during the forecast period 2022-2027.
The global artificial intelligence/machine learning medical device market was valued at $4,011.7 million in 2022 and is anticipated to reach $35,458.2 million by 2032, witnessing a CAGR of 24.35% during the forecast period 2022-2032.
The global deep venous disease treatment devices market was valued at $1,119.3 million in 2022 and is anticipated to reach $2,419.2 million by 2032, witnessing a CAGR of 7.72% during the forecast period 2023-2032.
The global dry X-Ray film market was valued at $924.7 million in 2022 and is anticipated to reach $1,112.2 million by 2032, witnessing a CAGR of 1.86% during the forecast period 2022-2032.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032.
The global surgical robotics market was valued at $8,705.3 million in 2022 and is anticipated to reach $18,410.9 million by 2032, witnessing a CAGR of 7.78% during the forecast period 2022-2032.
The global cell and gene therapy biomanufacturing market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031.
The global medical X-Ray detectors market was valued at $2,167.0 million in 2022 and is anticipated to grow to $3,702.0 million by the end of 2032, at a projected CAGR of 5.50% during the forecast period 2022-2032.
The U.S. DTC wellness testing market is projected to reach $4,946.3 million by 2032 from $878.9 million in 2022, at a CAGR of 18.86% during the forecast period 2022-2032.
The U.S. orthopedic imaging modalities market was valued at $2,697.8 million in 2022 and is anticipated to grow to $3,989.9 million by the end of 2031, at a projected CAGR of 4.44% during the forecast period 2022-2031.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.
The U.S. women health laboratory testing market was valued at $72.8 billion in 2021 and is anticipated to reach $106.8 billion by 2030, witnessing a CAGR of 4.30% during the forecast period 2022-2030.
The global NGS informatics market was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032.
The U.S. prostate cancer testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030.
In 2021, the global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
The global wearable patches market was valued at $8,650.0 million in 2021 and is projected to reach $26,892.7 million by the end of 2031.
The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032.
The report focuses solely on the extensive stage small cell lung cancer treatment, which includes approved products as well as products under clinical development.
The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032.
The U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is forecasted to reach $29.28 billion by 2032.
The global flow cytometry in oncology and immunology market was valued at $1,653.2 million in 2021 and is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The global laboratory informatics market was valued at $4,341.2 million in 2021 and is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032.
In 2021, the global NGS kits market was valued at $4,553.6 million, and it is expected to reach $26,057.4 million by 2032, growing at a CAGR of 17.27% during the forecast period 2022-2032.
The Middle East and North Africa laparoscopy devices market was valued at $752.0 million in 2021 and is anticipated to reach $1,731.4 million by 2031, witnessing a CAGR of 7.71% during the forecast period 2022-2031.
The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022-2031.
The global ambulatory surgical center operating room integration systems market is projected to reach $5,668.2 million by 2032 from $2,077.5 million in 2021, at a CAGR of 9.88% during the forecast period 2022-2032.
The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032.
In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.
The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032.
The global gastrointestinal endoscopy market was valued at $13.40 billion in 2021 and is anticipated to reach $25.75 billion by 2031, witnessing a CAGR of 6.24% during the forecast period 2022-2031.
In 2021, the global NGS library preparation automation market was valued at $1,273.2 million, and it is expected to reach $3,803.3 million by 2029, growing at a CAGR of 14.85% during the forecast period 2022-2029.
The report provides an exhaustive list of pipeline products which are currently in the development along with their developmental details in various indications.
The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032.
The market size of MR imaging in neurosurgery was valued at $88.7 million in 2021 and is anticipated to reach $150.5 million by the end of 2031, registering a CAGR of 5.52% during the forecast period 2022-2031.
The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032.
The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at a CAGR value of 12.24% during the forecast period 2022-2032.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.
In 2021, the global clinical biomarkers market was valued at $21,304.3 million, and it is expected to reach $54,294.0 million by 2032, growing at a CAGR of 8.73% during the forecast period 2022-2032.
The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.
The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032.
The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032.
The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032.
The global laparoscopy and endoscopy devices market was valued at $23,809.2 million in 2021 and is projected to reach $38,942.2 million by the end of 2031, growing at a CAGR of 4.94% during the forecast period 2022-2031.
In 2021, the global microbiome therapeutics market valued $306.3 million, and it is estimated to reach $3,204 million by 2032, registering a CAGR of 24.95% during the forecast period 2022-2032.
The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032.
The global endoscopic imaging systems market was valued at $3,641.3 million in 2021 and is projected to reach $6,941.3 million by 2030.
The global NGS oncology market is projected to reach $51,783.0 million in 2032 from 14,828.6 million in 2021, witnessing a CAGR of 12.04% during the forecast period 2022-2032.
The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from $2,606.5 million in 2021, at a CAGR of 14.23% during the forecast period 2022-2032.
The global next-generation oncology devices and solutions market was valued at $3,268.2 million in 2021 and is projected to reach $5,971.3 million by 2031.
The market size of digital biomanufacturing was valued at $15,768.9 million in 2021 and is anticipated to reach $55,564.9 million by the end of 2031, registering a CAGR of 13.12% during the forecast period 2022-2031.
The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%.
The U.S. solid tumor testing market is projected to reach $18,287.6 million by 2032 from $9,498.8 million in 2021, at a CAGR of 6.19% during the forecast period 2022-2032.
The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the forecast period 2021-2031.
The global liquid biopsy market is projected to reach $19,066.0 million by 2032 from $2,508.2 million in 2021 at a CAGR of 19.83% during the forecast period 2022-2032.
In 2021, the Middle East liquid biopsy market was valued at $43.7 million, and it is expected to reach $175.2 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.